Artículos por temáticas

The Effect of APOE ε4 on Alzheimer's Disease Fluid Biomarkers: A Cross-Sectional Study Based on the COAST

Zhao B, Zang P, Quan M, Wang Q, Guo D, Jia J, Wang W.

CNS Neurosci Ther. 2025 Jan;31(1):e70202. doi: 10.1111/cns.70202.

The roles of functional bacterial amyloids in neurological physiology and pathophysiology: Pros and cons for neurodegeneration

Halimi H, Ahmadi B, Asri N, Rostami-Nejad M, Houri H.

Microb Pathog. 2025 Mar;200:107363. doi: 10.1016/j.micpath.2025.107363. Epub 2025 Feb 3.

Longitudinally persisting KCNA2-autoantibodies in mild amnestic dementia with Alzheimer´s pathology - Report and literature review

Hansen N, Teegen B, Hirschel S, Fox J, Fitzner D, Wiltfang J, Bartels C.

Behav Brain Res. 2025 Mar 28;482:115437. doi: 10.1016/j.bbr.2025.115437. Epub 2025 Jan 22.

How Histone Sensing Drives Alzheimer's Disease

Wu JP.

Front Biosci (Landmark Ed). 2025 Feb 18;30(2):33444. doi: 10.31083/FBL33444.

Menopausal hormone therapy is associated with worse levels of Alzheimer's disease biomarkers in APOE ε4-carrying women: An observational study

Jauregi-Zinkunegi A, Gleason CE, Bendlin B, Okonkwo O, Hermann BP, Blennow K, Zetterberg H, Hogervorst E, Johnson SC, Langhough R, Mueller KD, Bruno D.

Alzheimers Dement. 2025 Feb;21(2):e14456. doi: 10.1002/alz.14456. Epub 2025 Jan 9.

A de novo, mosaic and complex chromosome 21 rearrangement causes APP triplication and familial autosomal dominant early onset Alzheimer disease

Ehn E, Eisfeldt J, Laffita-Mesa JM, Thonberg H, Schoumans J, Portaankorva AM, Viitanen M, Lindstrand A, Nennesemo I, Graff C.

Sci Rep. 2025 Jan 23;15(1):2912. doi: 10.1038/s41598-025-86645-0.

A neuropathology case report of a woman with Down syndrome who remained cognitively stable: Implications for resilience to neuropathology

Liou JJ, Lou J, Flores-Aguilar L, Nakagiri J, Yong W, Hom CL, Doran EW, Totoiu MO, Lott I, Mapstone M, Keator DB, Brickman AM, Wright ST, Nelson B, Lai F, Xicota L, Dang LT, Li J, Santini T, Mettenbur

Alzheimers Dement. 2025 Feb;21(2):e14479. doi: 10.1002/alz.14479. Epub 2025 Jan 27.

Histone deacetylase's regulates Tau function in Alzheimer's disease

Chinnathambi S.

Adv Protein Chem Struct Biol. 2025;143:339-361. doi: 10.1016/bs.apcsb.2024.09.008. Epub 2024 Oct 7.

Nuclear Tau accumulation in Alzheimer's disease

Chinnathambi S, Velmurugan G, Suresh S, Adithyan A, Chandrashekar M.

Adv Protein Chem Struct Biol. 2025;143:323-337. doi: 10.1016/bs.apcsb.2024.06.003. Epub 2024 Jun 21.

The impact of sleep and exercise on brain atrophy in mild cognitive impairment

Mian M, Tahiri J, Habbal S, Aftan F, Reddy PH.

Mech Ageing Dev. 2025 Feb;223:112023. doi: 10.1016/j.mad.2024.112023. Epub 2024 Dec 26.

Iatrogenic cerebral amyloid angiopathy and Alzheimer's disease co-pathology

Hernández-Fernández F, Martínez-Fernández I, Barbella-Aponte R, Vilar IF, Ayo-Martín O, García-García J, Collado R, Andrés A, Hernández-Guillamón M, Pena Pardo FJ, Barrena C, de la Fuente M, Serrano-H

Ann Clin Transl Neurol. 2025 Jan;12(1):235-241. doi: 10.1002/acn3.52278. Epub 2024 Dec 27.

Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference

Kloske CM, Mahinrad S, Barnum CJ, Batista AF, Bradshaw EM, Butts B, Carrillo MC, Chakrabarty P, Chen X, Craft S, Da Mesquita S, Dabin LC, Devanand D, Duran-Laforet V, Elyaman W, Evans EE, Fitzgerald-B

Alzheimers Dement. 2025 Jan;21(1):e14291. doi: 10.1002/alz.14291. Epub 2024 Dec 18.

Differences in lean mass and sarcopenia between individuals with Alzheimer's disease and those without dementia: A systematic review and meta-analysis of observational studies

Nazareth CCG, Scalli ACAM, de Oliveira MPB, Gomes AFS, Brito-Costa S, Furtado GE, Cezar NOC.

J Alzheimers Dis. 2025 Jan;103(1):92-107. doi: 10.1177/13872877241299051. Epub 2024 Dec 16.

The emerging roles of particulate matter-changed non-coding RNAs in the pathogenesis of Alzheimer's disease: A comprehensive in silico analysis and review

Zeng HX, Qin SJ, Andersson J, Li SP, Zeng QG, Li JH, Wu QZ, Meng WJ, Oudin A, Kanninen KM, Jalava P, Dong GH, Zeng XW.

Environ Pollut. 2025 Feb 1;366:125440. doi: 10.1016/j.envpol.2024.125440. Epub 2024 Dec 2.

The role of inhibitory immune checkpoint receptors in the pathogenesis of Alzheimer's disease

Salminen A.

J Mol Med (Berl). 2025 Jan;103(1):1-19. doi: 10.1007/s00109-024-02504-x. Epub 2024 Nov 27.